Navigation Links
Sperian Respiratory Protection USA Awarded a 65,000 Reusable Respirator Order by the Veterans Health Administration
Date:7/12/2010

SANTA ANA, Calif., July 12 /PRNewswire/ -- The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers.  This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.

Recent studies have underscored the difficulties of communicating when wearing respiratory equipment.  A study by The National Center for Occupational Health and Infection Control, Veterans Health Administration was published in the Journal of Occupational and Environmental Hygiene, "Diminished Speech Intelligibility Associated with Certain Types of Respirators Worn by Healthcare Workers"* focused on communication interference associated with various disposable and half-mask respirators on the market today.

The Institute of Medicine (IOM) had identified communication interference as a key issue to be studied in speech intelligibility. Communication interference is a concern with some respirators commonly used by U.S. healthcare workers.  The objective of the VHA study was to determine speech intelligibility and auditory clarity of respirators commonly worn in a healthcare setting as compared to Surgical Masks and no respiratory protective equipment.  Disposable, reusable and powered air purifying respirators (PAPR) were among those included in the study. The study looked at the percentage of words spoken and understood while the healthcare worker wore various types of respiratory protection devices.

Wearing half-face elastomeric respirators with voice augmentation equipment was associated with higher speech intelligibility than models without this equipment. The data shows a statistically significant difference in word intelligibility when comparing half-face elastomeric models equipped with and without speech augmentation devices.  The study concluded that this problem may be partially mitigated by wearing half-face elastomeric models with "speaking membranes," or voice augmentation devices that are associated with higher word intelligibility than those without such devices.  PAPR respirators produce noise that can interfere with the hearing capability of the wearer.  All respiratory protective devices were well tolerated for the duration of the study.

The Survivair Blue1 Half Mask with Speaking Diaphragm equipped with P100 Filters was among the highest rated and best performing reusable half mask respirator for speech tangibility.

The Survivair Blue1 with Speaking Diaghram is the only half-mask respirator available with a silicone, dual sealing flange skirt which offers a better sealing surface for keeping a tight seal and comfortable fit on healthcare workers. P100 Filters provide a 99.97% filtration efficiency. Special modifications were made to the standard Survivair Blue1 specifically for the needs of the healthcare market. Splash guards for P100 filters were designed to keep patients from contaminating the filters. A sweep back exhalation valve cover was also developed to divert a worker's exhaled breath away from the patient. These modifications created the Survivair Blue1 H-Version.

After analysis of the peculiar problems faced by healthcare workers, Sperian developed a modified half-mask product in a special configuration, packaged to meet the specific needs in the VHA. The Sperian H-Version Blue1 reusable elastomeric half-mask with Speaking Diaphragm provides the healthcare industry a single package that can be deployed to healthcare workers in a pandemic or when there is a shortage of disposable respirators.  The VHA configuration package contains a fully assembled Sperian Blue1 H-Version respirator ready for donning, and a set of replacement P100 filters.

Sperian's focus on the intimate relationship with its end users was instrumental in quickly adapting the product and changes to meet the needs and requests of the VHA.  Modification of the existing model required new NIOSH approval for the Sperian Blue1 H-Version.  Sperian's full respirator product design, test and manufacturing capabilities were deployed to obtain prompt NIOSH approval and ramp up production to meet delivery commitments.

For more information, check www.sperian.com or contact Vick Sarkissian, Sr. Product Manager, at Sperian Respiratory Protection USA, LLC, 3001 South Susan Street, Santa Ana, CA 92704. He can be phoned at 714 427 5204 or emailed at vsarkissian@sperian.com.

About Sperian Protection

With nearly 6,000 employees worldwide, Sperian Protection (formerly Bacou-Dalloz) is the world's leading manufacturer of personal protective equipment. Sperian's expertise focuses on head, body and fall protection products including; hearing, eye and respiratory protection, protective apparel, safety harnesses, belts, anchors and fall prevention systems.

* Radonovich Jr., Lewis J., Yanke, Robert, Cheng, Jing and Bender, Bradley (2009),'Diminished Speech Intelligibility Associated with Certain Types of Respirators Worn by Healthcare Workers', Journal of Occupational and Environmental Hygiene, 7: 1, 63-70, First Published on: 10 November 2009 (iFirst)


'/>"/>
SOURCE Sperian Respiratory Protection USA, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
2. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
3. MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
4. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
5. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
6. Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive
7. QVA149 Phase II Data Presented at the European Respiratory Society Annual Meeting
8. PARI Respiratory Launches PEP S
9. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
10. OxySure(R) Aids Student in School Respiratory Arrest: WFAA Channel 8 News
11. Reportlinker Adds Chinese Markets for Respiratory Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
(Date:2/24/2017)... -- ITL Limited, ( ASX : ITD ), une société ... les excellents résultats semestriels clos le 31 décembre 2016 ... complète « Résultats et mise à jour sur la croissance ... Faits marquants ... en hausse de 104 %) Bénéfice par ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) ... Meeting. KLS is a longtime supporter of the event. , "We are pleased ... Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):